NCT01919996View on ClinicalTrials.gov

PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
PharyngitisTonsillitis
Interventions
DRUG

Azithromycin

Azithromycin oral suspension (immediate release) 12 mg/kg/day x 5 days

Trial Locations (6)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

60614

Outpatient Center in Lincoln Park, Chicago

60647

Infant Welfare Society of Chicago, Chicago

84107

Murray Pediatrics, Murray

84124

Daynes Eye and Lasik, Salt Lake City

95670

Martel Eye Medical Group, Rancho Cordova

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01919996 - PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients | Biotech Hunter | Biotech Hunter